Zebrafish-Based Small Molecule Discovery

Slides:



Advertisements
Similar presentations
1 Image-Based Biomedical Big Data Analytics Jens Rittscher Department of Engineering Science, Nuffield Department of Medicine, University of Oxford.
Advertisements

John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Toward the development of podocyte-specific drugs
An Introduction to Medicinal Chemistry 3/e
Volume 11, Issue 8, Pages (August 2004)
Volume 22, Issue 5, Pages v-vi (May 2015)
MEK Inhibitors Reverse cAMP-Mediated Anxiety in Zebrafish
Synthetic Strategies for Studying Embryonic Development
Volume 15, Issue 6, Pages (June 2012)
Enzyme Annotation with Chemical Tools
The Use of Zebrafish to Understand Immunity
Volume 14, Issue 5, Pages (May 2007)
Scratch n’ Screen for Inhibitors of Cell Migration
Zebrafish as a Model System to Study Skin Biology and Pathology
Novel Developments in Endoscopic Mucosal Imaging
Huimin Na, Olga Ponomarova, Gabrielle E. Giese, Albertha J.M. Walhout 
Volume 10, Issue 9, Pages (September 2003)
Volume 14, Issue 11, Pages (November 2007)
Volume 14, Issue 4, Pages (October 2006)
Researchers Find Their Nemo
Volume 17, Issue 9, Pages (May 2007)
Volume 20, Issue 12, Pages (December 2013)
ADP-Specific Sensors Enable Universal Assay of Protein Kinase Activity
John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews 
Biofilm Inhibitors that Target Amyloid Proteins
Volume 19, Issue 7, Pages (July 2012)
Volume 22, Issue 10, Pages (October 2015)
Volume 22, Issue 7, Pages (July 2015)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
A Noncanonical Path to Mechanism of Action
Masaoki Kawasumi, Paul Nghiem  Journal of Investigative Dermatology 
Volume 10, Issue 5, Pages (February 2015)
Imaging in Systems Biology
Volume 22, Issue 3, Pages (March 2015)
Raluca Ostafe, Radivoje Prodanovic, Jovana Nazor, Rainer Fischer 
How Chemoproteomics Can Enable Drug Discovery and Development
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Volume 3, Issue 6, Pages (December 2017)
Potent and Selective Peptidyl Boronic Acid Inhibitors of the Serine Protease Prostate- Specific Antigen  Aaron M. LeBeau, Pratap Singh, John T. Isaacs,
Toward a Science of Computational Ethology
Volume 18, Issue 11, Pages (November 2011)
Toward the development of podocyte-specific drugs
Adam P. Deveau, Victoria L. Bentley, Jason N. Berman 
Volume 17, Issue 1, Pages (January 2010)
Volume 23, Issue 10, Pages (October 2016)
Volume 19, Issue 7, Pages (July 2012)
Identification of Small Molecule Inhibitors that Distinguish between Non-Transferrin Bound Iron Uptake and Transferrin-Mediated Iron Transport  Jing Xu.
Volume 25, Issue 11, Pages (November 2017)
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors
Volume 10, Issue 8, Pages (August 2003)
Volume 21, Issue 9, Pages (September 2014)
Volume 9, Issue 1, Pages (January 2016)
A Suppression Strategy for Antibiotic Discovery
Volume 22, Issue 7, Pages (July 2015)
Volume 21, Issue 8, Pages (August 2014)
Cristina Esteva-Font, Puay-Wah Phuan, Marc O. Anderson, A.S. Verkman 
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E
Volume 22, Issue 11, Pages (November 2015)
Volume 11, Issue 3, Pages (March 2004)
Volume 26, Issue 4, Pages e6 (April 2019)
Shelley R Starck, Harry M Green, José Alberola-Ila, Richard W Roberts 
Huimin Na, Olga Ponomarova, Gabrielle E. Giese, Albertha J.M. Walhout 
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Adam P. Deveau, Victoria L. Bentley, Jason N. Berman 
Volume 18, Issue 11, Pages (November 2011)
Spatial Regulation of Developmental Signaling by a Serpin
Volume 17, Issue 8, Pages (August 2010)
Select: Symmetry Breaking
Volume 10, Issue 7, Pages (February 2015)
Presentation transcript:

Zebrafish-Based Small Molecule Discovery Calum A. MacRae, Randall T. Peterson  Chemistry & Biology  Volume 10, Issue 10, Pages 901-908 (October 2003) DOI: 10.1016/j.chembiol.2003.10.003

Figure 1 Organism- versus Target-Based Small Molecule Discovery Target-based discovery, such as discovery of cox-2 inhibitors (top), begins with selection of a molecular target, followed by screening for chemical modifiers of the target's activity. The true biological effect (phenotype) is only determined at the end of the process when efficacy and safety are tested in animals and man. In contrast, organism-based discovery begins with detection of desirable phenotypes in whole organisms and may lead to discovery of novel targets. For example, the discovery of dicumarol began as an observation of hemorrhaging in cattle and proceded to identification of vitamin K epoxide reductase as its target (bottom). Chemistry & Biology 2003 10, 901-908DOI: (10.1016/j.chembiol.2003.10.003)

Figure 2 Zebrafish Attributes Facilitate High-Throughput Screening (A) Zebrafish larvae 6 days post fertilization possess most of the tissues and organs of the fully developed vertebrate. (B) Zebrafish embryos fit easily in the wells of a standard 384-well compound screening plate. (C) The visibility of anatomic features can be increased by tissue-specific expression of fluorescent proteins. The larva shown expresses green fluorescent protein in the pituitary, driven by the proopiomelanocortin gene promoter [12] (image courtesy of S. Lin and N. Liu). (D and E) Lipid metabolism can be rapidly assayed using fluorescently quenched phospholipids. Cleavage in vivo is manifest by accumulation of fluorescent products in the gall bladder. fat free mutants process the substrate less efficiently, resulting in decreased fluorescence. (Images in [D] and [E] are reprinted with permission from [15]. Copyright 2001, American Association for the Advancement of Science.) Chemistry & Biology 2003 10, 901-908DOI: (10.1016/j.chembiol.2003.10.003)

Figure 3 Screening for Chemical Modifiers of Vertebrate Development Adult zebrafish lay hundreds of fertilized eggs each morning. Embryos are arrayed in assay plates, and compounds from small molecule libraries are added to the water in each well. Embryos are allowed to develop and are screened visually for developmental defects. Examples of specific developmental phenotypes include elongation of the notochord (A), absence of blood ([B], untreated, upper; treated, lower), and loss of a single otolith in the ear (C). Chemistry & Biology 2003 10, 901-908DOI: (10.1016/j.chembiol.2003.10.003)

Figure 4 High-Throughput Assays of Cardiovascular Physiology (A) Automated video microscopy captures 15 s videos of zebrafish hearts in 96- or 384-well plates. Data from one 384-well plate can be acquired in less than 2 hr. Light intensity in the region of the heart is plotted as a function of time. (B) Computer algorithms automatically extract physiological data from the videos, including heart rate. (C) High-throughput screens can be used to detect individual compounds or combinations that affect cardiovascular physiology [37]. In this example, a QT prolonging interaction between erythromycin and cisapride was detected. Atrial rate is plotted against increasing doses of cisapride. Erythromycin concentrations are indicated in the inset. Erythromycin and cisapride alone have little effect on heart rate, but together they cause severe bradycardia. (Images courtesy of David Milan.) Chemistry & Biology 2003 10, 901-908DOI: (10.1016/j.chembiol.2003.10.003)